Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The transaction marks a clear portfolio reshuffle for Indoco
Panacea Biotec receives LoA from CMSS
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
The approved Lacosamide Oral Solution is bioequivalent and therapeutically equivalent to the reference drug and will be manufactured at Indoco’s facility in Verna Industrial Area, Goa
Rivaroxaban is used to treat venous thromboembolism
Allopurinol is used to prevent or lower high uric acid levels in the blood
Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024
Indoco is comprehensively working on the remedial action plan
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
Subscribe To Our Newsletter & Stay Updated